65 related articles for article (PubMed ID: 27488577)
1. L1CAM as a prognostic marker in stage I endometrial cancer: a validation study.
Smogeli E; Davidson B; Cvancarova M; Holth A; Katz B; Risberg B; Kristensen G; Lindemann K
BMC Cancer; 2016 Aug; 16():596. PubMed ID: 27488577
[TBL] [Abstract][Full Text] [Related]
2. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression.
Park S; Cho Y; Kim HS
Anticancer Res; 2023 Oct; 43(10):4559-4571. PubMed ID: 37772557
[TBL] [Abstract][Full Text] [Related]
3. L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer.
Romanová M; Židlík V; Javůrková V; Kondé A; Šimetka O; Klát J
In Vivo; 2023; 37(5):2334-2339. PubMed ID: 37652517
[TBL] [Abstract][Full Text] [Related]
4. The sL1CAM in sera of patients with endometrial and ovarian cancers.
Wojciechowski M; Głowacka E; Wilczyński M; Pękala-Wojciechowska A; Malinowski A
Arch Gynecol Obstet; 2017 Jan; 295(1):225-232. PubMed ID: 27832351
[TBL] [Abstract][Full Text] [Related]
5. Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease.
Lien HE; Berg HF; Halle MK; Trovik J; Haldorsen IS; Akslen LA; Krakstad C
EBioMedicine; 2023 Jun; 92():104595. PubMed ID: 37146405
[TBL] [Abstract][Full Text] [Related]
6. Druggable genetic targets in endometrial cancer
Lehrer S; Rheinstein PH
Cancer Treat Res Commun; 2022; 30():100502. PubMed ID: 34933203
[TBL] [Abstract][Full Text] [Related]
7. L1CAM: amending the "low-risk" category in endometrial carcinoma.
Kommoss F; Kommoss F; Grevenkamp F; Bunz AK; Taran FA; Fend F; Brucker SY; Wallwiener D; Schönfisch B; Greif K; Lax S; Staebler A; Kommoss S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):255-262. PubMed ID: 27695947
[TBL] [Abstract][Full Text] [Related]
8. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
[TBL] [Abstract][Full Text] [Related]
9. L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.
van der Putten LJ; Visser NC; van de Vijver K; Santacana M; Bronsert P; Bulten J; Hirschfeld M; Colas E; Gil-Moreno A; Garcia A; Mancebo G; Alameda F; Trovik J; Kopperud RK; Huvila J; Schrauwen S; Koskas M; Walker F; Weinberger V; Minar L; Jandakova E; Snijders MP; van den Berg-van Erp S; Matias-Guiu X; Salvesen HB; Amant F; Massuger LF; Pijnenborg JM
Br J Cancer; 2016 Sep; 115(6):716-24. PubMed ID: 27505134
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
Corrado G; Laquintana V; Loria R; Carosi M; de Salvo L; Sperduti I; Zampa A; Cicchillitti L; Piaggio G; Cutillo G; Falcioni R; Vizza E
J Exp Clin Cancer Res; 2018 Jul; 37(1):139. PubMed ID: 29980240
[TBL] [Abstract][Full Text] [Related]
11. Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
Tangen IL; Kopperud RK; Visser NC; Staff AC; Tingulstad S; Marcickiewicz J; Amant F; Bjørge L; Pijnenborg JM; Salvesen HB; Werner HM; Trovik J; Krakstad C
Br J Cancer; 2017 Sep; 117(6):840-847. PubMed ID: 28751757
[TBL] [Abstract][Full Text] [Related]
12. Prognostic benefit of TILs independent of clinicopathological and molecular factors.
Brummel K; Eerkens AL; de Bruyn M; Nijman HW
Br J Cancer; 2023 Sep; 129(5):737-738. PubMed ID: 37443345
[No Abstract] [Full Text] [Related]
13. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Horeweg N; Workel HH; Loiero D; Church DN; Vermij L; Léon-Castillo A; Krog RT; de Boer SM; Nout RA; Powell ME; Mileshkin LR; MacKay H; Leary A; Singh N; Jürgenliemk-Schulz IM; Smit VTHBM; Creutzberg CL; Koelzer VH; Nijman HW; Bosse T; de Bruyn M;
Nat Commun; 2022 Mar; 13(1):1373. PubMed ID: 35296668
[TBL] [Abstract][Full Text] [Related]
14. Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target.
Li J; Zhou J; Huang H; Jiang J; Zhang T; Ni C
Clin Transl Med; 2023 Feb; 13(2):e1199. PubMed ID: 36808888
[TBL] [Abstract][Full Text] [Related]
15. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
Zhang K; Xie X; Zou LH; Guo SQ
Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
[TBL] [Abstract][Full Text] [Related]
16. FBXW7, L1CAM, and TGM2 in endometrial cancer.
Lehrer S; Rheinstein PH
Cancer; 2021 Nov; 127(21):4103-4104. PubMed ID: 34324708
[No Abstract] [Full Text] [Related]
17. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
Trüb M; Zippelius A
Front Immunol; 2021; 12():674565. PubMed ID: 34054861
[TBL] [Abstract][Full Text] [Related]
18. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
19. High L1CAM expression predicts poor prognosis of patients with endometrial cancer: A systematic review and meta-analysis.
Guo M; Gong H; Nie D; Li Z
Medicine (Baltimore); 2021 Apr; 100(13):e25330. PubMed ID: 33787629
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer.
Horeweg N; de Bruyn M; Nout RA; Stelloo E; Kedziersza K; León-Castillo A; Plat A; Mertz KD; Osse M; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; van der Steen-Banasik EM; Smit VT; Creutzberg CL; Bosse T; Nijman HW; Koelzer VH; Church DN
Cancer Immunol Res; 2020 Dec; 8(12):1508-1519. PubMed ID: 32999003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
